2120 Quality of life analysis in patients with RAS wild-type metastatic colorectal cancer treated with first-line FOLFIRI + cetuximab in the CRYSTAL study. (September 2015) - Yamaguchi, K.; Ando, M.; Ooki, A.; Beier, F.; Guenther, S.; Hohnhorst, P Von; Van Cutsem, E.